StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report issued on Thursday morning. The brokerage issued a buy rating on the stock.
Mannatech Trading Down 11.5 %
NASDAQ MTEX opened at $10.43 on Thursday. The company has a market capitalization of $19.61 million, a price-to-earnings ratio of -12.88 and a beta of 1.18. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. Mannatech has a 12 month low of $6.75 and a 12 month high of $13.00. The company’s fifty day moving average price is $8.55 and its two-hundred day moving average price is $7.79.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- EV Stocks and How to Profit from Them
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
